🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/12/2018 | 84,35 | 90,14 | 81,42 | 82,84 | -0,58% | 10,35% | 1.192.472 |
| 18/12/2018 | 84,08 | 84,08 | 81,87 | 83,32 | +0,82% | 2,63% | 774.730 |
| 17/12/2018 | 85,22 | 87,97 | 81,93 | 82,64 | -3,21% | 7,09% | 1.163.457 |
| 14/12/2018 | 87,76 | 89,30 | 84,56 | 85,38 | -3,47% | 5,40% | 1.295.224 |
| 13/12/2018 | 92,98 | 92,98 | 88,02 | 88,45 | -4,16% | 5,33% | 789.798 |
| 12/12/2018 | 92,31 | 94,73 | 91,45 | 92,28 | +0,93% | 3,56% | 569.867 |
| 11/12/2018 | 94,25 | 96,23 | 90,61 | 91,43 | -1,38% | 5,96% | 598.721 |
| 10/12/2018 | 91,35 | 93,99 | 90,02 | 92,71 | +2,07% | 4,35% | 790.760 |
| 07/12/2018 | 95,17 | 96,30 | 89,80 | 90,84 | -5,19% | 6,83% | 717.343 |
| 06/12/2018 | 93,99 | 95,95 | 92,02 | 95,81 | +0,53% | 4,17% | 929.419 |
| 04/12/2018 | 101,50 | 101,65 | 94,52 | 95,30 | -5,79% | 7,03% | 938.076 |
| 03/12/2018 | 99,89 | 102,27 | 98,74 | 101,16 | +2,78% | 3,53% | 719.106 |
| 30/11/2018 | 102,97 | 103,88 | 97,57 | 98,42 | -4,16% | 6,13% | 1.071.926 |
| 29/11/2018 | 100,62 | 103,49 | 99,69 | 102,69 | +1,20% | 3,77% | 627.895 |
| 28/11/2018 | 97,12 | 102,98 | 96,34 | 101,48 | +4,69% | 6,83% | 806.950 |
| 27/11/2018 | 96,50 | 99,43 | 95,06 | 96,94 | -0,22% | 4,53% | 953.304 |
| 26/11/2018 | 94,84 | 98,23 | 93,87 | 97,15 | +3,96% | 4,60% | 647.452 |
| 23/11/2018 | 93,34 | 97,01 | 93,33 | 93,45 | -1,11% | 3,95% | 247.022 |
| 21/11/2018 | 93,76 | 95,84 | 93,01 | 94,50 | +1,76% | 3,01% | 445.634 |
| 20/11/2018 | 91,12 | 96,06 | 89,92 | 92,86 | +0,22% | 6,74% | 922.527 |
| 19/11/2018 | 95,98 | 96,22 | 92,05 | 92,66 | -3,83% | 4,34% | 769.280 |
| 16/11/2018 | 94,02 | 97,60 | 90,77 | 96,36 | +1,68% | 7,27% | 818.812 |
| 15/11/2018 | 92,00 | 95,57 | 90,82 | 94,77 | +2,78% | 5,16% | 736.899 |
| 14/11/2018 | 93,49 | 94,45 | 89,36 | 92,20 | -0,42% | 5,44% | 1.062.629 |
| 13/11/2018 | 97,10 | 98,62 | 91,77 | 92,60 | -4,53% | 7,05% | 1.114.245 |
| 12/11/2018 | 98,18 | 100,03 | 96,23 | 96,99 | -1,97% | 3,88% | 1.035.538 |
| 09/11/2018 | 104,88 | 105,56 | 97,34 | 98,93 | -7,36% | 7,83% | 1.321.674 |
| 08/11/2018 | 109,79 | 114,58 | 102,31 | 106,79 | +5,04% | 11,18% | 2.521.359 |
| 07/11/2018 | 100,79 | 103,30 | 99,88 | 101,67 | +1,88% | 3,40% | 1.348.444 |
| 06/11/2018 | 99,31 | 101,15 | 98,07 | 99,80 | +0,41% | 3,10% | 1.347.963 |